These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31707555)

  • 1. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.
    Akbari M; Hassan-Zadeh V
    Inflammopharmacology; 2020 Apr; 28(2):345-362. PubMed ID: 31707555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms of macrophage activation in type 2 diabetes.
    Ahmed M; de Winther MPJ; Van den Bossche J
    Immunobiology; 2017 Oct; 222(10):937-943. PubMed ID: 27613200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of Epigenetics in Inflammation and Immunometabolism.
    Raghuraman S; Donkin I; Versteyhe S; Barrès R; Simar D
    Trends Endocrinol Metab; 2016 Nov; 27(11):782-795. PubMed ID: 27444065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes.
    Zatterale F; Raciti GA; Prevenzano I; Leone A; Campitelli M; De Rosa V; Beguinot F; Parrillo L
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental origins of type 2 diabetes: Focus on epigenetics.
    Vaiserman A; Lushchak O
    Ageing Res Rev; 2019 Nov; 55():100957. PubMed ID: 31473332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.
    Sommese L; Zullo A; Mancini FP; Fabbricini R; Soricelli A; Napoli C
    Epigenetics; 2017 Jun; 12(6):401-415. PubMed ID: 28059593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and Type 2 Diabetes Risk.
    Dhawan S; Natarajan R
    Curr Diab Rep; 2019 Jun; 19(8):47. PubMed ID: 31250127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes.
    Gilbert ER; Liu D
    Epigenetics; 2012 Aug; 7(8):841-52. PubMed ID: 22810088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and inflammatory markers in prediabetes and diabetes.
    Luc K; Schramm-Luc A; Guzik TJ; Mikolajczyk TP
    J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32084643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on epigenetics as a missing link between obesity and type 2 diabetes.
    Dobosz AM; Dziewulska A; Dobrzyń A
    Postepy Biochem; 2018 Oct; 64(2):157-165. PubMed ID: 30656898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and Immunometabolism in Diabetes and Aging.
    Guzik TJ; Cosentino F
    Antioxid Redox Signal; 2018 Jul; 29(3):257-274. PubMed ID: 28891325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets.
    Szabó M; Máté B; Csép K; Benedek T
    Biochem Genet; 2018 Dec; 56(6):553-574. PubMed ID: 29872933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening baroreflex sensitivity on progression to type 2 diabetes: localized vs. systemic inflammation and role of antidiabetic therapy.
    Bakkar NZ; Mougharbil N; Mroueh A; Kaplan A; Eid AH; Fares S; Zouein FA; El-Yazbi AF
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E835-E851. PubMed ID: 32865011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen-Derived Anti-Inflammatory Cytokine IL-10 Stimulated by Adipose Tissue-Derived Stem Cells Protects Against Type 2 Diabetes.
    Zhang J; Deng Z; Jin L; Yang C; Liu J; Song H; Han W; Si Y
    Stem Cells Dev; 2017 Dec; 26(24):1749-1758. PubMed ID: 29032727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
    Naidoo V; Naidoo M; Ghai M
    Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes.
    Dhawan P; Vasishta S; Balakrishnan A; Joshi MB
    Life Sci; 2022 Jun; 298():120490. PubMed ID: 35331720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in the pathogenesis of type 2 diabetes.
    Kaimala S; Ansari SA; Emerald BS
    Vitam Horm; 2023; 122():147-169. PubMed ID: 36863792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.
    Nicholas DA; Andrieu G; Strissel KJ; Nikolajczyk BS; Denis GV
    Cell Mol Life Sci; 2017 Jan; 74(2):231-243. PubMed ID: 27491296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.